Development of a Standardized Drug Nomenclature in France
The unique and unambiguous identification of drugs is fundamental to ensure interoperability between the different IT processes involved in the exchange of drug data. We present the RUIM (Unique drug interoperability nomenclature), which is based on an ontological model representing the different le...
Saved in:
Published in | Studies in health technology and informatics Vol. 327; p. 198 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
15.05.2025
|
Subjects | |
Online Access | Get more information |
ISSN | 1879-8365 |
DOI | 10.3233/SHTI250301 |
Cover
Summary: | The unique and unambiguous identification of drugs is fundamental to ensure interoperability between the different IT processes involved in the exchange of drug data. We present the RUIM (Unique drug interoperability nomenclature), which is based on an ontological model representing the different levels of entities that make up the French drug description. The RUIM integrates different levels of abstraction suitable for specific use cases (e.g. prescription under Nonproprietary Names with virtual drugs). The RUIM is intended to be mapped to international standards such as IDMP. It contains 132 000 concepts and can be viewed and downloaded at https://smt.esante.gouv.fr/. |
---|---|
ISSN: | 1879-8365 |
DOI: | 10.3233/SHTI250301 |